SCHEDULE OF WARRANTS (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Warrants | |||
| Number of warrants, outstanding, ending balance | 12 | 212 | |
| Weighted average exercise price, outstanding, beginning balance | $ 500 | $ 500 | |
| Weighted average remaining contract term, outstanding | 7 months 6 days | 10 months 6 days | 4 months 28 days |
| Intrinsic value, outstanding, beginning balance | |||
| Number of warrants, issued | |||
| Weighted average exercise price, issued | |||
| Number of warrants, expired | (200) | ||
| Weighted average exercise price, expired | |||
| Number of warrants, exercised | |||
| Weighted average exercise price, exercised | |||
| Number of warrants, expired | 200 | ||
| Number of warrants, outstanding, ending balance | 12 | 12 | 212 |
| Weighted average exercise price, outstanding, ending balance | $ 500 | $ 500 | $ 500 |
| Intrinsic value, outstanding, ending balance | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock warrants into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock warrants of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|